Although current evidence supports broad applicability across BMI, diabetes status, and fibrosis stages F2-F3, subgroup analyses suggest attenuated responses in non-obese patients and in certain ethnic groups (Hispanic patients in ESSENCE), emphasizing the need for precision medicine approaches incorporating anthropometric, genetic (e.g., PNPLA3, HSD17B13), and metabolic profiling
As more studies unfold and demand continues to grow, patients must stay informed and cautious
But foods that fill you up and keep you satisfiedparticularly, protein, fat, and fibertrigger a greater release of GLP-1
Insulinotropin: glucagon-like peptide 1 (737) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas
Mounjaro and Zepbound contain tirzepatide, which targets that hormone plus another one involved in metabolism
In retatrutide, the GLP-1 and GIP components offset this effect, keeping blood sugar stable while still capturing glucagon's fat-burning benefits (Jastreboff et al., NEJM 2023)
